Condition: Atrial Fibrillation (AF) · Sponsor: Seoul St. Mary's Hospital
The goal of this clinical trial is to learn whether a genetic risk score can help identify undiagnosed atrial fibrillation (AF) in adults who may have it. AF is an irregular heartbeat that raises the risk of stroke if not treated early. The main questions it aims to answer are: Can a polygenic risk score (PRS) - a score based on a person's genes - identify who is more likely to have AF? Does combining PRS with a person's medical history predict AF better than using medical history alone? Participants will: Wear a continuous ECG patch for 7 days to record heart rhythm Give a blood sample for genetic testing to calculate their PRS Use a six-lead handheld ECG device (HATIV® P30, VUNO Inc., Seoul, Republic of Korea) to check their own heart rhythm at home once or twice a week for 1 year Visit the clinic 5 times over 1 year Researchers will use the genetic and clinical information collected to build a scoring system that predicts who is at risk for AF.
This description comes directly from the study's public registry record.
Young Choi, MD, PhD · 82-2-1588-1511 · superstar@catholic.ac.kr
Always discuss trial participation with your own doctor first.
| The Catholic University of Korea Incheon St. Mary's Hospital | Incheon, South Korea | Recruiting |
| The Catholic University of Korea Seoul St. Mary's Hospital | Seoul, South Korea | Recruiting |
| The Catholic University of Korea Eunpyeong St. Mary's Hospital | Seoul, South Korea | Recruiting |
| The Catholic University of Korea St. Vincent's Hospital | Suwon, South Korea | Recruiting |
| The Catholic University of Korea Uijeongbu St. Mary's Hospital | Uijeongbu-si, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07641582